Biogen Inc.
BIIB
$147.37
$3.602.50%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.45% | 0.04% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.45% | 0.04% | |||
| Cost of Revenue | -8.64% | 27.26% | |||
| Gross Profit | 2.41% | -6.92% | |||
| SG&A Expenses | 17.65% | 4.83% | |||
| Depreciation & Amortization | -30.16% | 49.94% | |||
| Other Operating Expenses | -17.60% | 11.06% | |||
| Total Operating Expenses | -1.41% | 17.46% | |||
| Operating Income | 3.23% | -36.15% | |||
| Income Before Tax | -35.37% | -35.45% | |||
| Income Tax Expenses | -60.32% | -45.70% | |||
| Earnings from Continuing Operations | -31.35% | -33.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.35% | -33.43% | |||
| EBIT | 3.23% | -36.15% | |||
| EBITDA | 2.55% | -27.68% | |||
| EPS Basic | -31.35% | -33.48% | |||
| Normalized Basic EPS | 19.76% | -38.76% | |||
| EPS Diluted | -31.54% | -33.50% | |||
| Normalized Diluted EPS | 19.76% | -38.80% | |||
| Average Basic Shares Outstanding | 0.00% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
